HK1231553A1 - 功能性細胞狀態的鑒定 - Google Patents

功能性細胞狀態的鑒定

Info

Publication number
HK1231553A1
HK1231553A1 HK17104907.5A HK17104907A HK1231553A1 HK 1231553 A1 HK1231553 A1 HK 1231553A1 HK 17104907 A HK17104907 A HK 17104907A HK 1231553 A1 HK1231553 A1 HK 1231553A1
Authority
HK
Hong Kong
Prior art keywords
identification
functional cell
cell states
states
functional
Prior art date
Application number
HK17104907.5A
Other languages
English (en)
Inventor
Bartlomiej Rajwa
T Vincent Shankey
Original Assignee
Asedasciences Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asedasciences Ag filed Critical Asedasciences Ag
Publication of HK1231553A1 publication Critical patent/HK1231553A1/zh

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30Prediction of properties of chemical compounds, compositions or mixtures
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00Subject matter not provided for in other groups of this subclass
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/40Searching chemical structures or physicochemical data
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Computing Systems (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physiology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
HK17104907.5A 2014-01-14 2017-06-02 功能性細胞狀態的鑒定 HK1231553A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461927247P 2014-01-14 2014-01-14
PCT/US2015/011441 WO2015109003A1 (en) 2014-01-14 2015-01-14 Identification of functional cell states

Publications (1)

Publication Number Publication Date
HK1231553A1 true HK1231553A1 (zh) 2017-12-22

Family

ID=52440877

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17104907.5A HK1231553A1 (zh) 2014-01-14 2017-06-02 功能性細胞狀態的鑒定

Country Status (12)

Country Link
US (3) US20150198584A1 (zh)
EP (1) EP3094974B1 (zh)
JP (1) JP6606100B2 (zh)
KR (1) KR102413041B1 (zh)
AU (2) AU2015206520B2 (zh)
CA (1) CA2972960C (zh)
DK (1) DK3094974T3 (zh)
ES (1) ES2728119T3 (zh)
HK (1) HK1231553A1 (zh)
IL (1) IL246734B (zh)
SG (1) SG11201705495XA (zh)
WO (1) WO2015109003A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150198584A1 (en) * 2014-01-14 2015-07-16 Asedasciences Ag Identification of functional cell states
CA2977481C (en) 2015-02-24 2021-02-02 The University Of Tokyo Dynamic high-speed high-sensitivity imaging device and imaging method
CN108351289B (zh) * 2015-10-28 2021-11-26 国立大学法人东京大学 分析装置
US10824693B2 (en) 2015-12-10 2020-11-03 Reservoir Labs, Inc. Systems and methods for selective expansive recursive tensor analysis
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
WO2018217933A1 (en) * 2017-05-25 2018-11-29 FlowJo, LLC Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets
EP4306931A3 (en) 2018-06-13 2024-02-07 ThinkCyte K.K. Methods and systems for cytometry
EP3969978A4 (en) 2019-05-14 2023-02-08 University of Pittsburgh - of the Commonwealth System of Higher Education SYSTEM AND METHOD FOR CHARACTERIZING CELLULAR PHENOTYPIC DIVERSITY USING MULTIPARAMETRIC CELLULAR AND SUBCELLULAR IMAGING DATA
WO2022026532A1 (en) * 2020-07-30 2022-02-03 Allen Institute Systems, devices, and methods for compound screening using predictive tagging
WO2023009513A1 (en) 2021-07-26 2023-02-02 Asedasciences Ag Improved methods for identification of functional cell states
WO2023056481A1 (en) * 2021-10-01 2023-04-06 CAP Diagnostics, LLC, dba Pathnostics Automated methods and systems for rapid identification of target particles
US20230119020A1 (en) * 2021-10-20 2023-04-20 Travera, Inc. Treatment response assessment using normalized single cell measurements

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544650A (en) 1988-04-08 1996-08-13 Neuromedical Systems, Inc. Automated specimen classification system and method
JPH08510051A (ja) * 1993-01-08 1996-10-22 クールター コーポレイション 保存対照細胞を蛍光および光散乱測定の校正において用いる方法
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US7166424B2 (en) 1998-02-02 2007-01-23 Odyssey Thera Inc. Fragments of fluorescent proteins for protein fragment complementation assays
US20050221280A1 (en) * 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6998249B1 (en) * 1999-09-27 2006-02-14 Pharmacia & Upjohn Company Toxicity screening method
US7912651B2 (en) 2000-03-06 2011-03-22 Bioseek Llc Function homology screening
WO2001092859A1 (en) 2000-06-02 2001-12-06 Medicometrics Aps Method and system for classifying a biological sample
US7146349B2 (en) * 2000-11-06 2006-12-05 International Business Machines Corporation Network for describing multimedia information
EP1625394A4 (en) * 2003-04-23 2008-02-06 Bioseek Inc METHOD FOR ANALYZING BIOLOGICAL DATA PROFILES
US20070087344A1 (en) 2003-04-23 2007-04-19 Bioseek, Inc. Methods for characterizing signaling pathways and compounds that interact therewith
WO2008134593A1 (en) 2007-04-25 2008-11-06 President And Fellows Of Harvard College Molecular circuits
US20130226469A1 (en) 2008-04-01 2013-08-29 Purdue Research Foundation Gate-free flow cytometry data analysis
US8831889B2 (en) 2008-04-01 2014-09-09 Purdue Research Foundation Quantification of differences between measured values and statistical validation based on the differences
US20150198584A1 (en) * 2014-01-14 2015-07-16 Asedasciences Ag Identification of functional cell states

Also Published As

Publication number Publication date
JP2017505140A (ja) 2017-02-16
KR20160110444A (ko) 2016-09-21
US11867690B2 (en) 2024-01-09
SG11201705495XA (en) 2017-08-30
CA2972960A1 (en) 2015-07-23
JP6606100B2 (ja) 2019-11-13
IL246734B (en) 2019-06-30
US20160370350A1 (en) 2016-12-22
AU2015206520B2 (en) 2021-07-22
WO2015109003A1 (en) 2015-07-23
ES2728119T3 (es) 2019-10-22
AU2021204419A1 (en) 2021-07-22
DK3094974T3 (da) 2019-05-27
US11137388B2 (en) 2021-10-05
US20150198584A1 (en) 2015-07-16
CA2972960C (en) 2022-01-11
EP3094974B1 (en) 2019-02-27
EP3094974A1 (en) 2016-11-23
IL246734A0 (en) 2016-08-31
KR102413041B1 (ko) 2022-06-23
US20210364499A1 (en) 2021-11-25
AU2015206520A1 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
IL274903A (en) cell
IL250511A0 (en) Crystalline forms of ibrutinib
HK1231553A1 (zh) 功能性細胞狀態的鑒定
SG11201609265RA (en) Characterizing states of subject
GB201419865D0 (en) Solution
GB201407805D0 (en) Battery condition determination
HUE045323T2 (hu) Elektrolit oldat
HK1231632A1 (zh) 電池
SG11201610831PA (en) Lithium-sulphur battery
SG11201610430QA (en) Growth-independent detection of cells
GB2531512B (en) Context-sensitive identification of regions of interest
GB201411985D0 (en) Battery
PL3149792T3 (pl) Ogniwo litowo-siarkowe
GB2531332B (en) Location identification
GB2559497B (en) Functional wall-tie
GB201414968D0 (en) Cell assay
GB201413459D0 (en) Identification of objects
GB201413650D0 (en) Wallets
GB201403494D0 (en) Identifying cell features
GB201410934D0 (en) T cell
GB201419149D0 (en) Wallet
GB201417979D0 (en) Abstract accelerationon
GB201419897D0 (en) Host cell
GB201418789D0 (en) Microcarriers
GB201418787D0 (en) Microcarriers